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Several parasitic species are well known to have carcinogenic properties, namely; Schistosoma hematobium (squamous cell
carcinoma of the bladder) and the liver ﬂukes Opisthorchis and Chlonorchis (cholangiocarcinoma). A large number of parasites
are known to colonize the gastrointestinal tract. We sought to review the evidence that implicates these parasites in gastrointestinal
neoplasia. Schistosoma japonicum, which is endemic primarily in east Asia, has been shown in multiple studies to convey a
mildly increased risk of colorectal adenocarcinoma. The data supporting a causative role for Schistosoma mansoni in colorectal or
other neoplastic processes are less convincing, limited primarily to small case-control studies and case series. Reports of possible
associations between other gastrointestinal parasites (e.g., E. histolytica and A. lumbricoides) and neoplasia may be found in the
literature but are limited to individual cases. We conclude that, other than S. japonicum and to a lesser extent S. mansoni, there is
little evidence of an association between gastrointestinal parasites and neoplasia.
1.Introduction
A wide variety of parasites are known to cause disease in
the human gastrointestinal tract, including some species that
are very prevalent over a large geographical area. Human
parasites are traditionally divided into two broad groups,
protozoa and helminths. The phylum protozoa includes
a number of gastrointestinal parasites, with some notable
members such as Entamoeba histolytica, Giardia lamblia,
Cryptosporidia,a n dTrypansoma cruzi. The multi cellu-
lar helminths are further divided into three groups, ces-
todes/tapeworms (e.g., Taenia solium and Diphyllobothrium
latum), nematodes/round worms (e.g., Ascaris lumbricoides,
Strongyloides stercoralis,a n dEnterobius vermicularis), and
trematodes/ﬂukes (e.g., Schistosoma japonicum and Schisto-
soma mansoni).
There has long been scientiﬁc interest in exploring the
possibility of infectious causes of cancer, including bacterial,
viral, and parasitic causes. Mathematical modeling has es-
timated that approximately 16% of cancers throughout the
world may be attributable to infection [1]. The fraction of
this that is attributable to parasitic infection is currently
unknown. Historically, one of the ﬁrst proposed links
between parasitosis and cancer garnered Dr. J. A. G. Fibiger
the Nobel Prize in 1926 for his work demonstrating that
mice infected with the nematode Spiroptera later developed
stomachcancer.Thisworkwaslaterdebunkedonatleasttwo
levels. It was shown that the risk of “cancer” was only seen in
a speciﬁc strain of mice, and later review actually challenged
whether the lesions in question were truly carcinomatous
in nature or just hyperplastic [2]. Despite this inauspicious
beginning, several parasites have subsequently been deﬁni-
tively shown to have carcinogenic properties. Associations
between S. hematobium and squamous cell carcinoma of the
bladderandtheliverﬂukes(OpisthorchisandClonorchis)and
cholangiocarcinomahavebeenwelldocumentedfordecades.
Thus, there is a body of evidence that links speciﬁc parasites
to nongastrointestinal malignancies. Despite the fact that the
gastrointestinal tract is the main site of infection for many2 Journal of Tropical Medicine
parasites, there has, to our knowledge, been no review that
explores the possible association between parasites of the
gastrointestinal tract and subsequent neoplasia.
2. Schistosomiasis
Schistosomiasis is a major worldwide health problem, with
an estimated 600 million at-risk people across 74 countries
and directly aﬀecting approximately 200 million people [3].
Schistosomes are dioecious trematodes that live in the blood
stream of humans and other animals and utilize fresh water
snailsasanintermediatehost.Theclinicalsyndromeofschis-
tosomiasis results primarily from the host response to the
deposited eggs rather than to the adult parasites, eliciting
a vigorous eosinophilic and granulomatous response, and
eventually ﬁbrosis. The severity of symptoms is related to the
number of eggs deposited in the tissue.
S. hematobium is endemic primarily in the Middle East,
particularly in Egypt. There is a wealth of epidemiologic,
experimental, and histopathologic data that link infection
by S. hematobium with squamous cell carcinoma of the
urinary bladder (reviewed in [4]). Most tellingly, as public
health measures have caused a decline in S. hematobium
in Egypt in the past decades, there has been a matching
decline in squamous cell carcinoma of the bladder [5, 6].
The pathogenesis of S. hematobium is thought to be related
to the chronic inﬂammatory response, resulting in increased
numbers of macrophages and neutrophils that release reac-
tive oxygen and nitrogen species that have the potential to
cause DNA damage [4, 7]. Two main schistosome species,
S. mansoni and S. japonicum,a ﬀect the gastrointestinal tract
and liver. S. mansoni is distributed in Africa, the Middle East,
and South America, while S. japonicum is found in China,
the Philippines, and Indonesia. S. japonicum was previously
endemic to Japan, but integrated control measures in place
since the 1920s eventually eradicated schistosomiasis in the
late 1970s [8]. Intestinal schistosomiasis provokes mucosal
granulomatous inﬂammation, pseudopolyposis, ulceration,
and superﬁcial bleeding, primarily in the colon and rectum.
Clinically, this is manifested most often as abdominal pain
and diarrhea, although quite frequently intestinal schistoso-
miasis is clinically occult [9].
3.Schistosoma japonicum
3.1. Association with Colorectal Carcinoma. A link between
S. japonicum and colorectal neoplasia has been debated for
decades. The ﬁrst reports on this topic began to appear in the
Englishliteratureinthelate1950’s[10].Sincethistime,there
have been a large number of patients reported individually
or in groups with both colorectal carcinoma and evidence
of infection by S. japonicum (reviewed in [11]). Case reports
and small case series continue to appear in the literature with
some regularity, including the authors of this paper [12–
15]. Many of these case reports and case series originated
in areas of endemic S. japonicum, including Japan, China,
and the Philippines, or from immigrants from these areas.
Although these types of investigations certainly provide
tantalizing evidence, case reports and series alone cannot
provide deﬁnitive evidence of a link between S. japonicum
and colorectal neoplasia.
A series of studies from China and Japan, published
between 1983 and 2005, examined this topic from an epi-
demiological and geographical standpoint, which were re-
viewed by the International Agency for the Research of Can-
cer (IARC) in 1994 [11, 16–20]. These studies analyzed the
correlation between mortality due to colorectal carcinoma
and that due to schistosomiasis in provinces of China with
variable levels of S. japonicum prevalence. Most found a pos-
itive and signiﬁcant correlation between cancers of the colon
and rectum and mortality due to schistosomiasis, although
all are to some extent confounded by diﬃculties in con-
trolling for inﬂuences such as diet and other causes of
colorectal cancer. In Xu and Su 1984 [18], colorectal cancer
mortality was compared to mortality due to S. japonicum
in two provinces in eastern China with variable levels of
schistosomiasis prevalence, including data over a three-year
period (1977–1979). The prevalence of schistosomiasis in
the studied areas ranged from 10% to 79%, as determined
by skin testing and rectal biopsy. The investigators found a
statistically signiﬁcant positive correlation (Spearman’s rank
correlation coeﬃcient,r = 0.68, P<0.01) betweenmortality
due to colorectal cancer and that due to S. japonicum.I n
comparison, there was no statistical relationship between
mortality due to S. japonicum and that due to lung cancer.
One of the ﬁrst case-control studies to examine the asso-
ciation between S. japonicum and colorectal cancer [21]
found that schistosomal eggs were more likely to be found in
patients with stomach and colorectal carcinoma than pa-
tients with benign disease. 1,458 resections of the gastroin-
testinal tract in Japan were reviewed, including 993 speci-
mens with benign processes and 465 with malignant tumors.
16.8% of the specimens with malignancy were found to also
show evidence of infection with S. japonicum,a sc o m p a r e d
to 9.6% of those with nonmalignant conditions, a diﬀerence
that was statistically signiﬁcant. Interestingly, patients with
malignant tumors in the 40–49-year-old age range were
muchmorelikelytoshowevidenceofS.japonicuminfection.
In Xu and Su 1984 [18], the investigators performed a case-
control series, comparing 252 patients with colorectal cancer
to matched lung cancer patients and healthy controls. This
study found a statistically signiﬁcant association between
rectal cancer and history of schistosomal infection (odds
ratio between 4.5 and 8.3 depending on the controls), but
no signiﬁcant association was found between colon cancer
and schistosomal infection. In another more recent case-
control series, 142 colon cancer patients were compared to
285 matched control patients in Sichuan, China [22]. Out
of 142 colon cancer patients, 42 (30%) gave a history of
previous S. japonicum infection, as compared to 14% of
the control patients. From this data, the authors reported
a statistically signiﬁcant association between S. japonicum
infection and colon cancer (odds ratio 3.3, P<0.01). Their
results indicate a fraction of disease attributable to schis-
tosomiasis of 24% for colon cancer. The investigators did not
speciﬁcally compare colon and rectal cancers with regards to
schistosomiasis.Journal of Tropical Medicine 3
Because squamous cell carcinoma of the bladder is rare
in the absence of S. hematobium infection, this link was
relativelysimpletoconclusivelyestablish.Incontrast,adeno-
carcinomas that arise in patients with S. japonicum infection
have few overt histopathological diﬀerences from those
not associated with schistosomiasis. However, a few studies
have noted subtle features that distinguish S. japonicum-
associated colorectal carcinomas from nonschistosomal-
associated cancers. Cancers arising in the context of S. japon-
icum infection tend to occur in young patients, with 57%
of S. japonicum-associated cancers being found in the 21–
40-year-old range, as compared to 39% of nonschistosomal-
associated colon cancers [23]. One study [24]c o m p a r e da
series of 289 S. japonicum-associated colorectal carcinomas
with 165 nonschistosomal associated colorectal carcinomas,
with the intent of identifying transitional mucosal changes
that might distinguish schistosomal-associated colorectal
cancers. Cancers associated with S. japonicum tended to be
more often well diﬀerentiated than controls (91.6% of schis-
tosomal-associated colorectal cancers were well diﬀerenti-
ated, as compared to 69.1% of nonschistosomal-associated
cancers), while control cases were more frequently associated
with adenomatous polyps. It was also noted in this study
that cancers associated with S. japonicum tended to occur in
youngerpatients(mean40.3years)thaninnonschistosomal-
associated cancers (mean 46.3), although no statistical sig-
niﬁcance was given. This group published a follow-up study
in 1981 that examined a subset of the previously published
group of S. japonicum-associated colorectal cancers [25].
This study reported that ﬂat epithelial dysplasia was found
in the 36 of 60 examined cases of schistosomal-associated
colorectal cancers. Also noted was a change in the distribu-
tion of Paneth cells, similar to that seen in inﬂammatory
bowel disease. The authors concluded that S. japonicum-
associated colorectal cancers tended to have features similar
to cancers arising in the context of inﬂammatory bowel dis-
ease, although this was not formally compared to a series of
matched controls.
The precise pathogenesis of S. japonicum-associated col-
orectal cancers remains enigmatic, although, as discussed
above,itappearsthatthechronicinﬂammatoryresponsedue
to deposited schistosome ova plays an etiologic role [26].
This topic is diﬃcult to study in a controlled setting, due to
the complex and lengthy life cycle of schistosome species and
the fact that the fresh water snails that act as intermediate
hosts are problematic to cultivate in aquaria, particularly the
species associated with S. japonicum [27]. Two studies have
reported an increased risk of hepatocellular carcinoma in
mice infected with S. japonicum ( r e v i e w e di n[ 27]), but no
similar animal model of S. japonicum driven colorectal car-
cinoma has been reported. Extracts of S. japonicum ova were
tested for direct mutagenicity using the Ames test [28]. No
evidence was found to suggest that ova release a mutagenic
factor. A series from Egypt attempted to identify immuno-
histochemical and molecular features that may distinguish
colorectal cancers that are associated with S. mansoni and
nonschistosomal-associated colorectal cancers [29]. Twenty-
four specimens with colorectal carcinoma with evidence of
S. mansoni were compared to 45 nonschistosomal-associated
colorectal cancers. There was no signiﬁcant relationship
between schistosomal status and p53 and c-myc expression.
BCL-2 expression was found to be more often positive in S.
mansoni-associated colorectal cancers (58.3% versus 33.3%
in nonschistosomal colorectal cancers, P = 0.046). Another
studyattemptedtoidentifycharacteristicmutationsinp53in
schistosomal and nonschistosomal-associated rectal cancers
[30]. In this study, twenty-two cases of rectal cancer with ev-
idence of S. japonicum and twenty-two nonschistosomal rec-
tal cancers were subjected to single strand conformational
polymorphism testing for p53 mutations and subsequent
sequencing. In schistosomal rectal cancers, thirteen p53 mu-
tations were identiﬁed in ten cases, most of which were
found to be base-pair substitutions, while thirteen mutations
were found in nine nonschistosomal rectal cancers. A higher
proportion of base-pair substitutions were found at CpG
dinucleotides in S. japonicum-associated rectal cancers as
compared to nonschistosomal rectal cancers, although this
diﬀerence did not reach statistical signiﬁcance. These ﬁnd-
ings led the authors to suggest that S. japonicum may release
a directly genotoxic agent. In summary, the pathogenesis of
S. japonicum-associated colorectal cancers may have some
similarities to those seen arising in the setting of in-
ﬂammatory bowel disease, but much remains unknown.
A few studies have endeavored to explore potential host
factors that could predispose patients to develop squamous
cell carcinomas of the bladder in the context of S. hemato-
bium. For instance, glutathione S-transferase gene deletions
were shown to be signiﬁcantly more common in patients
with S. hematobium-associated squamous cell carcinomas
of the bladder [31]. Similarly, a speciﬁc arylamine N-acetyl
transferase genotype was found to be more prevalent in
patients with S. hematobium-associated squamous cell car-
cinoma of the bladder [32]. To date, no similar studies have
been performed in S. japonicum-associated colorectal can-
cer. In the approaching era of relatively inexpensive and
widely available high throughput gene sequencing, it will be
fascinating to ascertain whether there are host factors that
predispose patients to the development of colorectal carci-
noma due to schistosomiasis.
The IARC formally reviewed the association between S.
japonicum and colorectal cancer in 1994, as part of a mon-
ograph examining the carcinogenic risks to humans of schis-
tosomes, liver ﬂukes, and Helicobacter pylori[ 11]. The IARC
found suﬃcient evidence to declare that S. hematobium
and species of Opisthorchis and Clonorchis were deﬁnitely
carcinogenic to humans. In this monograph, the IARC
concluded that S. japonicum is possibly carcinogenic to hu-
mans. Since this monograph was published, only a handful
of additional studies have been published on this topic,
although at least one additional case control study published
in 2005 did ﬁnd epidemiological evidence again implicating
S. japonicum as a causative agent in colorectal carcinoma
[22].
3.2. Association with Cancers of Other Sites. In addition to
the very probable link between S. japonicum and colorectal
malignancy, there is evidence that implicates this parasite
in hepatocellular carcinogenesis. An epidemiological study4 Journal of Tropical Medicine
of 907 patients with chronic liver disease from Japan found
that 19% of patients with nonneoplastic chronic liver disease
and 51% of patient with hepatocellular carcinoma showed
evidence of infection by S. japonicum,ad i ﬀerence that was
found to be statistically signiﬁcant [33]. In the same study,
a 10-year prospective case-control study found that chronic
hepatic schistosomiasis conveyed roughly the same risk for
development of hepatocellular carcinoma as other causes
of chronic hepatitis such as HCV, although note was made
in this study that there were a high number of cases that
showed coinfection by HCV and S. japonicum, possibly
biasing the data. In a mouse model, it was demonstrated that
S. japonicum infected mice were at signiﬁcantly increased
risk of hepatocellular carcinoma. Out of 61 mice with
hepatic infection by S. japonicum, 48 had single or multiple
hepatocellular carcinomas [34]. Similar ﬁndings have been
shown in experimental models examining mice infected by
S. japonicum and then also given carcinogenic agents [27].
Besides colorectal and hepatic neoplasia, there is no sig-
niﬁcant or consistent evidence of an association between S.
japonicum and cancers of other sites. A few studies have
peripherally addressed a potential link between S. japonicum
and cancers of the stomach and esophagus. Several case
series of gastric cancer associated with S. japonicum infection
have been published from both China and Japan (reviewed
in [11]). In one of the early epidemiologic studies [17],
signiﬁcantpositivecorrelationwasfoundinasingleprovince
between mortality due to S. japonicum and cancers of the
stomach and esophagus, but results from other provinces
were inconsistent. In a similar study [16], no positive cor-
relation was found between prevalence of S. japonicum in-
fection and cancers of the stomach and esophagus. Overall,
there appears little but limited, anecdotal evidence to suggest
that there is a link between gastric and esophageal neoplasia
and infection by S. japonicum.
A few individual cases have been reported of other neo-
plasms with evidence of infection by S. japonicum, including
gastrointestinal tumors. A case of a rectal carcinoid was de-
scribed with evidence of S. japonicum in a 44-year-old Phil-
ippines-born female patient [35]. In a series of 26 goblet
cell carcinoids of the appendix, three were found to also
show S. japonicum eggs in the appendiceal wall [36]. A
few case reports exist in the literature that also describe S.
japonicum ova associated with nongastrointestinal tumors,
such as squamous cell carcinoma of the skin [37], malignant
schwannoma [38], bronchogenic carcinoma [39], and breast
carcinoma [40]. Given the paucity of these reports, it is
most likely that these represent extraordinary coincidences
rather than evidence of a causative role for the parasite in
carcinogenesis.
4.Schistosoma mansoni
4.1. Association with Colorectal Carcinoma. Patients, both
individually and in small series, with evidence of both
colorectal adenocarcinoma and S. mansoni infection have
been reported for decades, primarily in the Middle East
[12, 41–43]. However, unlike S. japonicum, there is a distinct
lack of epidemiological evidence that links the geographical
distribution of S. mansoni to cancers of any type, gastroin-
testinal or otherwise. In one series, a large group of patients
in an area of endemic S. mansoni (Egypt) underwent lower
endoscopy and biopsy. Of 638 patients with biopsies, 219
had histologic evidence of S. mansoni infection, while 26
had colorectal adenocarcinoma. However, only two patients
in this series had evidence of both S. mansoni infection
and colorectal adenocarcinoma, leading the authors to
conclude that there was no causative role for S. mansoni
in colorectal neoplasia [44]. In another more recent study,
histopathologic and genetic changes in 40 schistosomal-
associated colorectal cancers were compared to 20 colorectal
cancers without evidence of schistosomiasis, all from an area
of endemic S. mansoni (Egypt). The authors found that
patientswithschistosomal-associatedcolorectalcancerswere
younger(averageage35versus51yearsfornonschistosomal-
associated cancers, P<0.0 5 )a n dm o r eo f t e nh a dm u l -
tiple synchronous tumors (20% of schistosomal-associated
cancers were synchronous as compared to 5% of non-
schistosomal cancers, P<0.05). Pathologically, colorectal
cancers associated with schistosomiasis were more often
mucinous (35% of schistosomal-associated with mucinous
histology versus 10%, P = 0.02) and tended to present
at high stage. Immunohistochemical staining revealed that
signiﬁcantly more schistosomal-associated colorectal cancers
overexpressed p53 (80% of schistosomal-associated cancers
versus 40%, P = 0.006). The authors speculated that p53
alterations may act as an inciting event in schistosomal-
associated neoplasia [45].
As discussed in the above section on S. japonicum,a
series of S. mansoni-associated colorectal cancers and non-
schistosomal colorectal cancers were found to show no sig-
niﬁcant diﬀerences in p53 and c-myc immunohistochemical
expression, but Bcl-2 was found to be signiﬁcantly more
likely to be expressed in S. mansoni-associated cancers [29].
A case series comparing 59 colorectal cancers in Egypt to a
variety of control cases originating from the USA found S.
mansoni ova in 32% of resection specimens, similar to the
reported prevalence in Egypt in the general population [46].
This study found that S. mansoni ova were more commonly
foundinMSI-Hcolorectalcancers(50%ofMSI-Hcancersas
comparedto22%ofmicrosatellitestablecancers,P = 0.002).
S. mansoni ova were also more frequent among patients
whose tumors showed KRAS mutations, although this was
seen only in a small number of patients (80% [4 of 5] of
patients with KRAS mutations had S. mansoni ova versus
31% of the 42 patients with no evidence of KRAS mutations,
P = 0.05).
Similar to S. japonicum, in 1994 the IARC formally re-
viewed the evidence for a causative link between S. mansoni
infection and colorectal adenocarcinoma [11]. The authors
of this monograph concluded that there is inadequate ev-
idence to classify S. mansoni as a carcinogenic agent in hu-
mans.
4.2. Association with Cancers of Other Sites. S. mansoni ova
have been reported as individual cases in a variety of other
nongastrointestinal tumors, including prostatic adenocarci-
noma [47], ovarian teratoma [48], uterine leiomyoma [49],Journal of Tropical Medicine 5
Table 1: Summary of evidence linking gastrointestinal parasites and neoplasia.
Parasite Cancer type Site Types of studies Probability of causation of
neoplasia
S. japonicum Adenocarcinoma Colon and rectum
Case-control studies,
epidemiological studies, case
series, and many case reports
Probable
S. mansoni Adenocarcinoma Colon and rectum Case-control studies, case reports Equivocal, weak association
E. histolytica Adenocarcinoma Colon Rare case reports Unlikely
A. lumbricoides Adenocarcinoma Biliary tract and
ampulla Rare case reports Unlikely
Anisakis Adenocarcinoma Colon Rare case reports Unlikely
G. lamblia Ductal
adenocarcinoma Pancreas Rare case reports Unlikely
squamous cell carcinoma of the uterine cervix [50], and
inﬂammatory myoﬁbroblastic tumor of the liver [51]. Other
than these few case reports, there is no evidence to suggest
that S. mansoni plays a causative role in the carcinogenesis of
malignancies of other sites.
5.Other Parasites
A number of reports in the literature discuss the wide variety
of parasites that may opportunistically infect immunosup-
pressed patients (reviewed in [52]). Similarly, a number of
reports may be found in the literature of parasitic infections
that were found to simulate malignant gastrointestinal
neoplasms (reviewed in [53]). Much more rare are reports
of parasitic infections that present concomitantly with
a ﬁrst-time diagnosis of gastrointestinal malignancy, that
could potentially speak to a carcinogenic role of the parasitic
infection. These reports are limited to individual reports and
very small case series. A case report from Zaire describes a
53-year-old male with a sigmoid colon carcinoma with liver
metastases. The tumor surface was found to be covered in
E. histolytica trophozoites [54]. There are at least three case
reports linking biliary ascariasis with extrahepatic cholan-
giocarcinoma and periampullary carcinoma. The ﬁrst report
described a 65-year-old male with obstructive jaundice. Im-
aging revealed linear structures suggesting biliary ascariasis.
The common bile duct and pancreatic region later were
found to have a coexistant periampullary carcinoma [55].
Two women in rural Malaysia presenting with obstructive
jaundice were both found to have imaging evidence of
ascariasis in the common bile duct. Both women underwent
surgery, revealing masses in the extrahepatic biliary tract
that proved to be cholangiocarcinoma, as well as grossly
identiﬁed worm parts in the biliary system [56]. The ﬁnal
reported case involved a 42-year-old male with obstructive
jaundice and imaging evidence of biliary ascariasis. The
worm was removed endoscopically, but jaundice persisted
due to a periampullary mass that was found to represent
a well-diﬀerentiated periampullary adenocarcinoma upon
resection [57]. Colonic anisakiasis has been reported in con-
junction with colorectal cancer twice, although one of these
actually showed anisakiasis of the ascending colon in the
context of a sigmoid colon cancer [58, 59]. Giardia infection
has been documented in pancreatic adenocarcinomas twice.
The ﬁrst was reported in a 59-year-old Japanese woman
with a hetergenous enhancing mass of the pancreas. ERCP
was performed, with brush cytology that revealed G. lamblia
t r o p h o z o i t e sb u tn oc a n c e r .Af o l l o w - u pE U S - F N Aam o n t h
later did identify adenocarcinoma, and a subsequent pancre-
aticoduodenectomy revealed a ductal adenocarcinoma [60].
The second report was that of a 69-year-old Japanese male
with a radiologically identiﬁed pancreatic tail mass. ERCP
with aspiration of the pancreatic juice revealed numerous G.
lamblia trophozoites. Subsequent distal pancreatectomy and
omentectomy revealed a well to moderately diﬀerentiated
ductal adenocarcoma with metastasis to the omentum [61].
Given the paucity of these reports, one must conclude that
these instances likely represent true coincidence and suggest
no role for these parasites in subsequent neoplastic transfor-
mation.
In addition, a few investigators have speciﬁcally ad-
dressed this potential link in larger studies and reviews for
a few selected gastrointestinal anatomic sites and parasitic
species. Infectious causes of esophageal neoplasia were re-
viewed by Eslick [62] who concluded that no parasites have
been linked with esophageal cancers, although intriguingly
noted that dogs are susceptible to a rare form of esophageal
cancer following infection by the esophageal parasite Spiro-
cerca lupi. A large group of patients with Chagas disease
(Trypansom cruzi) in South America were examined, and no
increased risk of gastrointestinal neoplasia was noted [63].
Although Echinococcus is not a gastrointestinal parasite, at
least one published report found that Echinococcal hydatid
cyst disease was signiﬁcantly less prevalent than what would
be expected given the prevalence in Turkey in a large group
of cancer patients, leading the authors to conclude that this
parasite may actually protect patients from neoplasia [64].
6. Conclusions
We have endeavored to review the literature that may dem-
onstrate a causative role for parasites in gastrointestinal
neoplasia, summarized in Table 1. The preponderance of
evidence shows that S. japonicum infection of the colon and
rectum conveys an increased risk for the development of
adenocarcinoma. The molecular mechanisms that underlie6 Journal of Tropical Medicine
this increased risk are not clear but are likely related to the
long-term inﬂammatory response, similar to inﬂammatory
bowel disease. The evidence linking S. mansoni infection and
colorectalneoplasiaisweaker,butatleastonestudydoessug-
gest that cancers arising in the setting of chronic S. mansoni
infectionhavedistinctivefeatures,resemblingcancersarising
in the setting of inﬂammatory bowel disease [45].
Despite a scattering of case reports and small case series,
there is no consistent or convincing evidence that links gas-
trointestinal neoplasia and any other parasite besides the
schistosome species. Is there simply no signiﬁcant relation-
ship between most gastrointestinal parasites and neoplastic
complications? Perhaps, but it is also possible that a weakly
increased risk may be impossible to prove statistically in
a parasite with low prevalence. Schistosomal infections are
a very common parasitic infection in humans, resulting in
a large infected population that facilitates epidemiological
studies. Even in the well-studied carcinogenic parasites such
as S. hematobium and the liver ﬂukes, the increased risk
of cancer is relatively low. It will require further very large
epidemiologic studies to show a statistically increased risk
of gastrointestinal neoplasia in parasites with low rates of
prevalence, if one exists at all.
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